N-Desmethyl Regorafenib N-Oxide

Synchemia is a leading supplier in pharmaceutical Regorafenib Impurities . Regorafenib (Stivarga) is an oral anti-cancer drug used for specific advanced cancers, primarily metastatic colorectal cancer (CRC), gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer), typically after other treatments have failed. It works as a kinase inhibitor, blocking signals that help cancer cells multiply, thereby slowing or stopping their spread .

N-Desmethyl Regorafenib N-Oxide CAS NO: 835621-12-0 chemically represented as  2-Carbamoyl-4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)pyridine 1-oxide . N-Desmethyl Regorafenib N-Oxide is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of N-Desmethyl Regorafenib N-Oxide . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.